Literature DB >> 1468905

MRI of intracranial arteries in nitroglycerin induced cluster headache attacks.

J Hannerz1, D Greitz.   

Abstract

Eight patients with episodic cluster headache, five in active episode, three out of episode, were investigated as to diameters of intracranial arteries before and after nitroglycerin (NG) administration. The diameter of all intracranial carotids were increased about 10 minutes after NG, although more in the patients in episode than in patients out of episode. The dilatation remained for the next 60 minutes in the patients who did not get a cluster headache attack. There was a normalization of the diameters of the internal carotid arteries compared to the initial values, at maximum pain in all patients who got a cluster headache attack. Similar changes were also found in the basilar arteries. The findings support the hypothesis of a constriction of intracranial arteries at maximum pain in cluster headache attacks to stop the pain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1468905     DOI: 10.1111/j.1526-4610.1992.hed3210485.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  3 in total

1.  Beta-oscillations in the posterior hypothalamus are associated with spontaneous cluster headache attack.

Authors:  Wido Nager; Thomas F Münte; Josep Marco-Pallares; Marcus Heldmann; Reinhard Dengler; Hans Holger Capelle; Götz Lütjens; Joachim K Krauss
Journal:  J Neurol       Date:  2010-05-14       Impact factor: 4.849

Review 2.  Cluster headache pathophysiology: What we have learned from advanced neuroimaging.

Authors:  Marcello Silvestro; Alessandro Tessitore; Ilaria Orologio; Giorgia Battista; Mattia Siciliano; Gioacchino Tedeschi; Antonio Russo
Journal:  Headache       Date:  2022-03-21       Impact factor: 5.311

3.  Comprehensive clinical phenotyping of nitroglycerin infusion induced cluster headache attacks.

Authors:  Diana Y Wei; Peter J Goadsby
Journal:  Cephalalgia       Date:  2021-02-20       Impact factor: 6.292

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.